Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs

MLA

Maria Luisa Jaén, et al. “Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs.” Molecular Therapy: Methods & Clinical Development, vol. 6, no. C, Sept. 2017, pp. 1–7. EBSCOhost, https://doi.org/10.1016/j.omtm.2017.03.008.

APA

Maria Luisa Jaén, Laia Vilà, Ivet Elias, Veronica Jimenez, Jordi Rodó, Luca Maggioni, Rafael Ruiz-de Gopegui, Miguel Garcia, Sergio Muñoz, David Callejas, Eduard Ayuso, Tura Ferré, Iris Grifoll, Anna Andaluz, Jesus Ruberte, Virginia Haurigot, & Fatima Bosch. (2017). Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs. Molecular Therapy: Methods & Clinical Development, 6(C), 1–7. https://doi.org/10.1016/j.omtm.2017.03.008

Chicago

Maria Luisa Jaén, Laia Vilà, Ivet Elias, Veronica Jimenez, Jordi Rodó, Luca Maggioni, Rafael Ruiz-de Gopegui, et al. 2017. “Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs.” Molecular Therapy: Methods & Clinical Development 6 (C): 1–7. doi:10.1016/j.omtm.2017.03.008.